Cargando…

Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer

IMPORTANCE: Suppression of thyrotropin (often referred to as thyroid-stimulating hormone, or TSH) with levothyroxine used in management of intermediate- and high-risk differentiated thyroid cancer (DTC) to reduce the likelihood of progression and death is based on conflicting evidence. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klubo-Gwiezdzinska, Joanna, Auh, Sungyoung, Gershengorn, Marvin, Daley, Brianna, Bikas, Athanasios, Burman, Kenneth, Wartofsky, Leonard, Urken, Mark, Dewey, Eliza, Smallridge, Robert, Chindris, Ana-Maria, Kebebew, Electron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484595/ https://www.ncbi.nlm.nih.gov/pubmed/30707227 http://dx.doi.org/10.1001/jamanetworkopen.2018.7754

Ejemplares similares

SAT519 Association of Free Thyroxine Level With Survival Outcome In Patients With Intermediate And High-Risk Differentiated Thyroid Cancer
por: Ghosh, Raisa, et al.
Publicado: (2023)

Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III)
por: Thakur, Shilpa, et al.
Publicado: (2019)

Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

THYROID EMERGENCIES
por: Ylli, Dorina, et al.
Publicado: (2019)

Levothyroxine Treatment in Pregnancy: Indications, Efficacy, and Therapeutic Regimen
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011)

A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology—A Pilot Cohort Study
por: Gomes-Lima, Cristiane J., et al.
Publicado: (2020)

Cytochrome C Oxidase Subunit 4 (COX4): A Potential Therapeutic Target for the Treatment of Medullary Thyroid Cancer
por: Bikas, Athanasios, et al.
Publicado: (2020)

Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011)

Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy
por: Jensen, Kirk, et al.
Publicado: (2020)

The utility of low-iodine diet in preparation for thyroid cancer therapy with radioactive iodine—A cohort study
por: Luo, Hongxiu, et al.
Publicado: (2022)

Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2017)

OR27-3 A Novel Risk Stratification System for Thyroid Nodules with Indeterminate Cytology: A Pilot Cohort Study
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

Assessment of Thyroid Function in Patients With Alkaptonuria
por: Avadhanula, Shirisha, et al.
Publicado: (2020)

FRI476 Asymptomatic Thyrotropin-secreting Pituitary Microadenoma With Biochemical Secondary Hyperthyroidism: A Diagnostic Conundrum
por: Al-Naqeeb, Ghadah, et al.
Publicado: (2023)

Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012)

Management Options for Advanced Low or Intermediate Grade Gastroenteropancreatic Neuroendocrine Tumors: Review of Recent Literature
por: Neychev, Vladimir, et al.
Publicado: (2017)

Multiple Transduction Pathways Mediate Thyrotropin Receptor Signaling in Preosteoblast-Like Cells
por: Boutin, Alisa, et al.
Publicado: (2016)

Thyrotropin Stimulates Differentiation Not Proliferation of Normal Human Thyrocytes in Culture
por: Morgan, Sarah J., et al.
Publicado: (2016)

Mitotane induces mitochondrial membrane depolarization and apoptosis in thyroid cancer cells
por: Bikas, Athanasios, et al.
Publicado: (2019)

β-Arrestin 1 in Thyrotropin Receptor Signaling in Bone: Studies in Osteoblast-Like Cells
por: Boutin, Alisa, et al.
Publicado: (2020)

SUN-553 Atypical Spindle Cells on a Thyroid Aspirate: A Rare Case of a Thyroid Schwannoma Presenting as a Progressively Expanding Thyroid Nodule
por: Gubbi, Sriram, et al.
Publicado: (2019)

TSH Receptor Homodimerization in Regulation of cAMP Production in Human Thyrocytes in vitro
por: Boutin, Alisa, et al.
Publicado: (2020)

Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors—A Cohort Study
por: Aswath, Kshama, et al.
Publicado: (2021)

SUN-118 Somatostatin Agonist Conjugated to the Evans Blue Moiety Is a Superior Analog in the Diagnosis and Treatment of Tumors Characterized by High Somatostatin Receptor Expression
por: Thakur, Shilpa, et al.
Publicado: (2020)

MON-514 Detection of RAS Mutations and RET/PTC Fusions in Thyroid Cancer Using Microfluidic Digital PCR
por: Ylli, Dorina, et al.
Publicado: (2020)

Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2022)

Response to Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2023)

SAT-575 Radiolabeled Somatostatin Receptor Analog (86)Y-EB-TATE is Characterized by Superior Tumor Uptake Compared to (68)Ga-DOTA-TATE and (68)Ga-DOTA-JR11 in Thyroid Cancer Mice Models
por: Thakur, Shilpa, et al.
Publicado: (2019)

Response to Letter to the Editor from Sukor et al.: “Evaluation and Treatment of Amiodarone-induced Thyroid Disorders”
por: Ylli, Dorina, et al.
Publicado: (2021)

Editorial: Novel Imaging Techniques in the Management of Thyroid Nodules and Autoimmune Thyroid Disease
por: Szczepanek-Parulska, Ewelina, et al.
Publicado: (2019)

MiR-20a Is Upregulated in Anaplastic Thyroid Cancer and Targets LIMK1
por: Xiong, Yin, et al.
Publicado: (2014)

OR09-5 mTOR Signaling is Associated with Regulation of Mitochondrial Respiration in Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2022)

The Molecular Landscape of Hürthle Cell Thyroid Cancer Is Associated with Altered Mitochondrial Function—A Comprehensive Review
por: Kumari, Sonam, et al.
Publicado: (2020)

Peptide Receptor Radionuclide Therapy in Thyroid Cancer
por: Gubbi, Sriram, et al.
Publicado: (2022)

Breathing the air of mitochondrial respiration via an important oncotarget - mitochondrial glycerophosphate dehydrogenase (mGPDH)
por: Thakur, Shilpa, et al.
Publicado: (2019)

Carfilzomib potentiates CUDC-101-induced apoptosis in anaplastic thyroid cancer
por: Zhang, Lisa, et al.
Publicado: (2016)

Can Reverse T3 Assay Be Employed to Guide T4 vs. T4/T3 Therapy in Hypothyroidism?
por: Gomes-Lima, Cristiane, et al.
Publicado: (2019)

Adrenocortical Carcinoma and Synchronous Malignancies
por: Guerrero, Marlon A., et al.
Publicado: (2010)

To the editor
por: Kebebew, Electron, et al.
Publicado: (2017)

Editorial: Translational Research in Thyroid Cancer
por: Vasko, Vasyl, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_pk7fok1o8vmobcl14rjm268nld